Psychologytoday iconPsychologytodaySep 8, 2026 ~7 min source read

Benzodiazepines, Kratom, and the Search for Relief in Midlife

A clinician explores why women in midlife often reach for substances such as benzodiazepines and kratom to quiet anxiety and fatigue, and what clinicians should consider beyond symptom suppression.

Benzodiazepines, Kratom, and the Search for Relief in Midlife

Share this story

Send the public story page.

Useful takeaways from this story.

Benzodiazepines can relieve symptoms but carry risks of physical dependence and difficult withdrawal when used long term.

Kratom is unregulated in the U.S., varies in potency, and can interact dangerously with alcohol, benzodiazepines, or opioids.

Clinicians should investigate underlying drivers of distress and offer alternatives beyond indefinite symptom suppression.

Why relief is not the same as treatment

Benzodiazepines have a legitimate medical role and can be essential for acute relief. The article stresses that relief alone is not a treatment plan. Benzodiazepines carry well-documented risks: physical dependence and potentially severe withdrawal. For women in midlife, these medication risks intersect with life-stage challenges such as perimenopausal changes in sleep and mood, combined caregiving and work responsibilities, and cumulative stressors.

Kratom appears in the clinician's caseload as an alternative some women pursue. Reasons include perceived naturalness, tradition, accessibility, and claims of energy alongside anxiety or pain relief. However, kratom products sold in the U.S. are not regulated like prescription drugs and can vary substantially in potency. That variability increases unpredictability of effects and risks.

A serious concern highlighted is concomitant use: people may take kratom while drinking alcohol, using prescribed benzodiazepines, or taking opioids. Because some components of kratom have opioid-like effects and many of these substances depress the central nervous system, combining them can raise the risk of excessive sedation and respiratory depression.

The author urges clinicians to adopt curiosity and patience when a woman presents with new or intensified anxiety. Instead of defaulting to symptom suppression, clinicians should consider hormonal, psychological, medical, and situational contributors. Questions about sleep disruption, onset and pattern of panic or anxiety, life stressors, caregiving burdens, and possible substance use should guide assessment.

Assess underlying causes before committing to long-term benzodiazepine treatment. Discuss the variable nature and regulatory gaps of kratom with patients who report using it. Screen for co-use of alcohol, benzodiazepines, and opioids and educate about interactive risks. When pharmacologic relief is necessary, pair it with plans for addressing root causes and, when appropriate, time-limited strategies to reduce dependence risk.

More context around this story.

Kevinmd iconKevinmdSep 24, 2026

Kratom bans confuse the leaf with a semisynthetic opioid

Consider what happened in Walker County, Georgia, in the fall of 2025. Multiple middle schoolers became ill after eating gummies at school, though even the eventual headcount was never fully settled, with local reports ranging from three to five students. Emergency room physicians diagnosed a kratom overdose based on t

Kratom Cases Climb Sharply Across The US
Drugs iconDrugsSep 22, 2026

Kratom Cases Climb Sharply Across The US

TUESDAY, Sept. 22, 2026 — Addiction treatment centers across the United States are seeing more patients who have become dependent on kratom and a stronger compound made from it, known as 7-OH. At the telehealth clinic Boulder Care, the share...

Loading more related stories...

Keep reading in the app

Open the app view to save this story, compare related coverage, and continue from the same source.

Open in app